Form 4: Orthofix Medical Inc. CEO Acquires Additional Shares
SEC Form 4 Filing
Orthofix Medical Inc.'s CEO, Massimo Calafiore, purchased 9,914 shares of common stock at an average price of $17.43 on March 5, 2025.
Summary
- On March 5, 2025, Massimo Calafiore, the President & CEO of Orthofix Medical Inc., acquired 9,914 shares of the company's common stock.
- The shares were purchased at an average price of $17.43.
- Following the transaction, Calafiore directly owns 222,404 shares, which includes 182,396 restricted stock units.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally a good sign, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's performance and future prospects. CEO's buying shares is generally seen as a positive sign.
Stakeholder Impact
- Shareholders may view the CEO's purchase as a positive signal.
- The transaction has a limited direct impact on employees, customers, suppliers, and creditors.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of the stock purchase transaction. |
| 03/06/2025 | Date of signature on the Form 4 filing. |
Keywords
Orthofix Medical Inc., Massimo Calafiore, stock purchase, Form 4, OFIX, CEO, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.